Garmendia, I. (., Pajares, M. (. J., Hermida-Prado, F. (., Ajona, D. (., Bertolo, C. (., Lavín, A. (., . . . Agorreta, J. (. (2019). YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib.
Chicago Style CitationGarmendia, I. (Irati)|||/items/2248461f-35b5-4d13-b706-f80b8e641c4e, et al. YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib. 2019.
MLA CitationGarmendia, I. (Irati)|||/items/2248461f-35b5-4d13-b706-f80b8e641c4e, et al. YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib. 2019.
Warning: These citations may not always be 100% accurate.